Sleep Quality in High School Students With Asthma

Sponsor
Columbia University (Other)
Overall Status
Completed
CT.gov ID
NCT03073187
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
36
2
11.8
18
1.5

Study Details

Study Description

Brief Summary

The overall goal of this project is to develop and to preliminarily validate a novel intervention to be delivered in the high school setting that integrates two evidence-based, school-based interventions for urban adolescents with proven efficacy: (1) Asthma Self-Management for Adolescents (ASMA), an intervention for adolescents with uncontrolled asthma and (2) the Sleep-Smart Program (Sleep-Smart), which focuses on sleep hygiene and behaviors in urban adolescents.

The aim for Phase I is to develop and integrate school-based interventions to improve asthma self-management and sleep hygiene in urban high school students via interviews.

The aims for Phase II are: (1) to evaluate the feasibility and acceptability of the intervention procedures; and (2) to assess the preliminary evidence of the effects of the intervention on improving sleep quality in urban high school students with persistent asthma over a 2-month follow-up period.

This record is for Phase I only.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Sleep quality among adolescents is poor and asthma's impact is significant among adolescents. Asthma control is an important risk factor for poor sleep and poor academic performance. In addition, poor asthma control, poor sleep hygiene, and poor sleep quality are more likely in urban settings. Interventions to promote sleep quality by targeting both asthma control and sleep hygiene in this vulnerable population are lacking.

    To adapt ASMA and Sleep-Smart, the investigators will use a 3-step iterative process that will consist of (1) interviewing high school students and their caregivers, (2) interviewing high school teachers and (3) conducting separate focus groups with students and caregivers. The investigators hypothesize that the intervention will be feasible and acceptable. This study is a multi-site trial and collaboration between Columbia University Medical Center and Rhode Island Hospital (RIH).

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    36 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    A Pilot Study to Improve Sleep Quality in Urban High School Students With Asthma
    Actual Study Start Date :
    Apr 17, 2017
    Actual Primary Completion Date :
    Apr 10, 2018
    Actual Study Completion Date :
    Apr 10, 2018

    Arms and Interventions

    Arm Intervention/Treatment
    Students: Step 1 Interviews

    20 adolescents with uncontrolled asthma and poor sleep [10 from New York City (NYC); 10 from Rhode Island (RI)] will provide information regarding their asthma and sleep routines, and on what they would like to see in an intervention targeting co-morbid asthma and poor sleep.

    Caregivers: Step 1 Interviews

    The caregivers of the 20 adolescents in this step [10 from NYC; 10 from RI] will be asked to provide information regarding their teenager's asthma and sleep routines, and on what they would like to see in an intervention targeting co-morbid asthma and poor sleep.

    Teachers: Step 2 Interviews

    4 high school teachers, 2 from NYC and 2 from RI, will review the developed intervention. They will provide their opinions about the appropriateness of the teaching methods and literacy level for adolescents.

    Students: Step 3 Focus Groups

    20 adolescents with uncontrolled asthma and poor sleep [10 from NYC; 10 from RI] will review the intervention providing feedback on its appropriateness and utility.

    Caregivers: Step 3 Focus Groups

    The caregivers of the 20 adolescents in this step [10 from NYC; 10 from RI] will review the intervention providing feedback on its appropriateness and utility in small groups.

    Outcome Measures

    Primary Outcome Measures

    1. Number of subjects successfully completing the interview [Up to 10 months]

      Subjects will be interviewed regarding their preference and opinions about adapted curriculum.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    13 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    ADOLESCENT-CAREGIVER DYADS (20 adolescents with persistent asthma and poor sleep, and their caregivers - 10 in Step 1 and 10 in Step 3)

    Inclusion Criteria:
    1. a prior asthma diagnosis in the prior 12 months;

    2. use of prescribed asthma medications;

    3. persistent asthma (defined as (i) daytime symptoms 3+ days a week, (ii) night awakenings 3+ nights per month, (iii) 2+ Emergency Department visits or (iv) 1+ hospitalization for asthma); and

    4. sleep duration < 8 hours

    Exclusion Criteria:
    1. report of prior diagnosis of a sleep disorder, such as sleep disordered breathing, restless leg syndrome, periodic limb movement syndrome;

    2. A Pediatric Sleep Questionnaire (PSQ) score of 0.33 or more, a well-validated measure of sleep disordered breathing risk;

    3. active immunotherapy;

    4. additional pulmonary disease; and

    5. significant developmental delay and/or severe psychiatric or medical conditions that preclude completion of study procedures or confound analyses.

    SCHOOL TEACHERS (4 high school teachers - 2 from New York and 2 from Rhode Island in Step 2)

    Inclusion Criteria:
    • Teach at the high school level.
    Exclusion Criteria:
    • Unwilling to participate in the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Columbia University New York New York United States 10032
    2 Rhode Island Hospital Providence Rhode Island United States 02903

    Sponsors and Collaborators

    • Columbia University
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    Investigators

    • Principal Investigator: Jean-Marie Bruzzese, PhD, Columbia University
    • Principal Investigator: Daphne Koinis-Mitchell, PhD, Rhode Island Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Jean-Marie Bruzzese, Professor of Applied Developmental Psychology (in Nursing), Columbia University
    ClinicalTrials.gov Identifier:
    NCT03073187
    Other Study ID Numbers:
    • AAAQ9707 - I
    • 1R21HD086448-01A1
    First Posted:
    Mar 8, 2017
    Last Update Posted:
    Mar 5, 2021
    Last Verified:
    Mar 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jean-Marie Bruzzese, Professor of Applied Developmental Psychology (in Nursing), Columbia University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 5, 2021